Differential interactions of nateglinide and repaglinide on the human β-cell sulphonylurea receptor 1

Diabetes

Volumn 51, Issue 9, 2002, Pages 2789-2795

  Hansen, Ann Maria K ^a   Christensen, Inge T ^a   Hansen, John Bondo ^a   Carr, Richard D ^a   Ashcroft, Frances M ^b   Wahl, Philip ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; NATEGLINIDE; POTASSIUM CHANNEL; PROTEIN; PROTEIN KIR6.2; REPAGLINIDE; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 1; TOLBUTAMIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG CONFORMATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; LIGAND BINDING; MEMBRANE CURRENT; MOLECULAR MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036723838     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.9.2789     Document Type: Article

References (38)

1. Electrophysiology of the pancreatic beta-cell
2. ATP-sensitive K+ channels and insulin secretion: Their role in health and disease
3. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells
4. Adenosine 5′-triphosphate-sensitive potassium channels
5. Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor
6. Association and stoichiometry of K(ATP) channel subunits
7. Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion
8. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel
9. Tissue specificity of sulfonylureas: Studies on cloned cardiac and β-cell K(ATP) channels
10. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels
11. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel
12. Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide
13. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: Implication for tetramer formation and allosteric coupling of subunits
14. Interactions of the sulfonylurea receptor 1 subunit in the molecular assembly of beta-cell K-ATP channels
15. Molecular structure of the glibenclamide binding site of the beta-cell K-ATP channel
16. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kff6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel
17. Repaglinide and related hypoglycemic benzoic acid derivatives
18. Pancreatic beta-cell K-ATP channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide
19. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels
20. MacroModel: An integrated software system for modeling organic and bioorganic molecules using molecular mechanics
21. Merck molecular-force field. IV. Conformational energies and geometries for mmff94
22. Semianalytical treatment of solvation for molecular mechanics and dynamics
23. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation
24. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: Comparison with the suffonylureas and nateglinide
25. Tissue selectivity of antidiabetic agent nateglinide: Study on cardiovascular and beta-cell K(ATP) channels
26. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure
27. Stimulation of insulin release by repaglinide and glimenclamide involves both common and distinct processes
28. Studies on the N-(trans-4-isopropylcylohexyl)-carbonyl-D-phenylalanin e (A-4166)receptor in HIT T-15 cells: Displacement of [3H] glibenclamide
29. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166)
30. Fate of 3H- and 14C-labelled A-4166 in pancreatic islets
31. Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: Comparison to sulfonylureas and repaglinide
32. Effects of the hypoglycaeniic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in beta TC3 cells and rat pancreatic beta cells
33. A4166, but not repaglinde stimulate Ca2+-evoked KATP-channel independent, secretion in rat pancreatic alpha- and beta-cells
34. Selectivity of prandial glucose regulators: Nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells
35. Tolbutamide stimulates exocytosis of glucagon by inhibition of a mitochondria-like ATP-sensitive K+ (KATP) conductance in rat pancreatic A-cells
36. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas
37. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells
38. Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells